APA Alıntı

Yokoyama, Y., Aiba, T., Ueda, N., Nakajima, K., Kamakura, T., Wada, M., . . . Kusano, K. (2020). Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A. J Cardiol Cases.

Chicago Stili Alıntı

Yokoyama, Yasuhiro, et al. "Subcutaneous and Transvenous Implantable Cardioverter Defibrillator in High-risk Long-QT Syndrome Type 3 Associated With Val411Met Mutation in SCN5A." J Cardiol Cases 2020.

MLA Alıntı

Yokoyama, Yasuhiro, et al. "Subcutaneous and Transvenous Implantable Cardioverter Defibrillator in High-risk Long-QT Syndrome Type 3 Associated With Val411Met Mutation in SCN5A." J Cardiol Cases 2020.